S-OPTICHARGE
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79418391
- Mark type
- Word mark
- Filed
- 10 Jan 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Brian P. Gregg
Goods and services
- Class 001 — Chemicals: Preparations being industrial chemicals for gene recombination for scientific or laboratory purposes; chemical reagents for genetic identity testing for non-medical purposes; chemical reagents for use in genetic research; chemical reagents, other than for medical or veterinary purposes; synthetic gene for research other than for medical purposes, namely, chemical reagents for use in genetic research; biological preparations for use in biotechnology being use in industry and science other than for medical purposes; chemicals for use in biotechnological product development; enzymes derived from biotechnological processes for use in industry; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; reagents for scientific and research use for use in scientific apparatus for chemical or biological analysis; stem cells other than for medical or veterinary purposes; stem cells for research purposes; stem cells for scientific purposes; cell growth media for growing cells for use in scientific research; cells for scientific or research laboratory purposes
- Class 040 — Treatment of materials: Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylated drugs; processing of chemicals
- Class 042 — Scientific and technological services: Scientific laboratory services for high-efficiency glycan analysis; culturing of cells for others for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid scientific analysis; scientific protein analysis; scientific toxicity analysis; analysis in the field of molecular biology; development of biotechnology; biotechnological research; biological analysis; biological research; research of biologics; biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; scientific analysis services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; animal genetic research; computer programming in the medical field; medical research laboratories; computer software technical support services relating to the management of medical image data, namely, troubleshooting of computer software problems; medicine research; scientific analysis and evaluation of medical product development; providing scientific information on the testing, inspection and research of medical products; evaluating of clinical trial progress, namely, quality control for others; conducting clinical trials for others
Owner
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Feb 2026 — PETITION TO REVIVE-GRANTED
- 23 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 29 Aug 2025 — REFUSAL PROCESSED BY IB
- 14 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 13 Aug 2025 — REFUSAL PROCESSED BY MPU
- 02 Jul 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 01 Jul 2025 — NON-FINAL ACTION WRITTEN
- 18 Jun 2025 — ASSIGNED TO EXAMINER